{"result": "(\"entity\"<|>DESNUTRICIÓN<|>EVENT<|>Desnutrición is a condition that can occur in patients with Cystic Fibrosis due to negative energy balances, leading to significant health risks.)\n##\n(\"entity\"<|>OSTEOPOROSIS<|>EVENT<|>Osteoporosis is a condition characterized by weakened bones and is prevalent among patients with EPOC and Cystic Fibrosis.)\n##\n(\"entity\"<|>OSTEOPENIA<|>EVENT<|>Osteopenia is a condition of lower than normal bone density, which is also prevalent in patients with Cystic Fibrosis.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes Mellitus is a chronic condition that can co-occur with Cystic Fibrosis, affecting nutritional management and treatment.)\n##\n(\"entity\"<|>VITAMINAS LIPOSOLUBLES<|>PERSON<|>Liposoluble vitamins, including A, D, and E, are essential for patients with Cystic Fibrosis and are recommended for supplementation.)\n##\n(\"relationship\"<|>EPOC<|>OSTEOPOROSIS<|>Patients with EPOC have a high prevalence of osteoporosis due to various factors including inflammation and medication use<|>8)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>OSTEOPOROSIS<|>Patients with Fibrosis Quística are at risk for developing osteoporosis due to malnutrition and other health factors<|>8)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>OSTEOPENIA<|>Patients with Fibrosis Quística often experience osteopenia as a result of nutritional deficiencies<|>7)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>DIABETES MELLITUS<|>Cystic Fibrosis can co-occur with Diabetes Mellitus, complicating nutritional management<|>6)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>VITAMINAS LIPOSOLUBLES<|>Supplementation with liposoluble vitamins is essential for patients with Fibrosis Quística to prevent deficiencies<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: de sujetos sanos de similar edad y sexo, se recomienda que el Z-Score se ajuste por la talla (o edad para la talla) para evitar sobreestimación de déficits en la densidad mineral ósea27, 52, 68.\n\nEn pacientes con EPOC, la prevalencia de osteoporosis y de fracturas es muy elevada. Los datos de prevalencia varían de 5 a 60%, dependiendo de los métodos diagnósticos utilizados, el contexto poblacional, la gravedad de la enfermedad y de otros factores moduladores (envejecimiento, tabaquismo, desnutrición, sarcopenia, limitación física o funcional, inflamación sistémica, uso de corticoides y alta prevalencia de deficiencia de vitamina D en personas con EPOC avanzada)37, 51.\n\nEn personas con BQ no está suficientemente estudiado; no obstante, existen series que apuntan que la prevalencia es muy elevada (osteoporosis 27% y osteopenia 59%)69.\n---\n566      BLOQUE: PATOLOGÍAS ESPECÍFICAS\n\n## 5. Objetivos del soporte nutricional en la fibrosis quística\n\n### 5.1. Tratamiento dietoterápico en la fibrosis quística\n\nDebido a que las personas con FQ tienen un riesgo importante de desarrollar desnutrición como consecuencia de balances energéticos negativos, se recomienda que su ingesta habitual aporte entre el 120 y el 200% de las calorías recomendadas para las personas sanas de su misma edad, con el objetivo de alcanzar un crecimiento y peso y composición corporal adecuados52 (tabla 7).\n\nLa distribución de macronutrientes respecto al valor calórico total es aproximadamente el 20% en forma de proteínas; entre el 40 y el 45% como carbohidratos y entre el 35 y el 40% grasas. Respecto a la calidad de lípidos, el objetivo inicial debe ser educar en lo que es una dieta saludable (con menos del 10% de grasas saturadas, menos del 1% de ácidos grasos (AG) trans, menos del 10% en forma de AG poliinsaturados y el resto a base de AG monoinsaturados). Esta distribución es, potencialmente, fácil de conseguir en nuestro medio incrementando el consumo de aceite de oliva (crudo y/o cocinado) y de frutos secos. La ingesta de fibra debería ser la recomendada para la población general.\n\nEn el tratamiento de la FQ, el consejo dietético junto con la fortificación de la dieta habitual, utilizando alimentos altamente energéticos (por ejemplo, en forma de batidos, chucherías, frutos secos, snacks, cremas, fritos, aceite añadido a las comidas elaboradas, etc.) son eficaces para incrementar las calorías totales ingeridas. La efectividad de los cambios conductuales ha sido demostrada en la FQ, especialmente en niños.\n\nCuando coexiste la FQ con la diabetes mellitus, el objetivo esencial debe ser mantener un buen estado nutricional. Por tanto, no se recomiendan restricciones dietéticas de carbohidratos si son necesarios para mantener el estado nutricional. En estos casos habrá que adecuar la medicación hipoglucemiante (generalmente insulina retardada o análogos lentos junto con ultrarrápidos) a la ingesta de los hidratos de carbono20. Aunque hasta ahora no es una alternativa real en la mayoría de los centros, el trasplante pulmonar es posible simultanearlo con el de páncreas aislado con drenaje entérico.\n\nTodos los pacientes con IPE deben recibir suplementación con vitaminas liposolubles A, D y E (tabla 6)52. El aporte farmacológico se ajustará en base a la medición de los niveles plasmáticos, que debe realizarse al menos una vez al año, y siempre que se produzcan cambios en el tratamiento de suplementación o en el de la malabsorción. Algunos autores proponen para todos los pacientes (con y sin IPE) la suplementación con vitamina E debido a su efecto protector sobre la oxidación de las lipoproteínas y sobre la peroxidación lipídica70.\n\nPara prevenir la osteoporosis y la osteopenia el consenso europeo recomienda mantener niveles séricos de 25-OH-vitamina D (medidos preferentemente al finalizar el invierno) por encima de 20 ng/ml, mientras que la Cystic Fibrosis Foundation recomienda por encima de 3071; esto suele conseguirse con dosis entre 800 y 4.000 UI de vitamina D diarias sin provocar efectos secundarios. En algunos estudios se han objetivado deficiencias de vitamina D de hasta casi el 90% en niños y adultos jóvenes (dependiendo del punto de corte), por lo que algunos autores defienden suministrar dosis mayores que las que proponen los consensos72.\n\nRespecto a la vitamina A, si se suplementa\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>EPOC<|>EVENT<|>EPOC, or Chronic Obstructive Pulmonary Disease, is a progressive lung disease that causes breathing difficulties and is associated with a high prevalence of osteoporosis and fractures among patients.)\n##\n(\"entity\"<|>FIBROSIS QUÍSTICA<|>EVENT<|>Fibrosis Quística, or Cystic Fibrosis, is a genetic disorder that affects the lungs and digestive system, leading to nutritional challenges and a risk of malnutrition.)\n##\n(\"entity\"<|>CYSTIC FIBROSIS FOUNDATION<|>ORGANIZATION<|>The Cystic Fibrosis Foundation is an organization that provides guidelines and recommendations for the treatment and management of Cystic Fibrosis, including nutritional support.)\n##\n(\"entity\"<|>VITAMINA D<|>PERSON<|>Vitamin D is a fat-soluble vitamin essential for maintaining bone health and is recommended for supplementation in patients with Cystic Fibrosis to prevent osteoporosis.)\n##\n(\"entity\"<|>VITAMINA A<|>PERSON<|>Vitamin A is a fat-soluble vitamin that may be supplemented in patients with Cystic Fibrosis to support overall health and prevent deficiencies.)\n##\n(\"relationship\"<|>EPOC<|>FIBROSIS QUÍSTICA<|>EPOC and Fibrosis Quística are both conditions that can lead to significant health challenges, including nutritional deficiencies and osteoporosis<|>3)\n##\n(\"relationship\"<|>CYSTIC FIBROSIS FOUNDATION<|>FIBROSIS QUÍSTICA<|>The Cystic Fibrosis Foundation provides guidelines for the management of Fibrosis Quística, including nutritional recommendations<|>7)\n##\n(\"relationship\"<|>VITAMINA D<|>FIBROSIS QUÍSTICA<|>Vitamin D supplementation is recommended for patients with Fibrosis Quística to prevent osteoporosis<|>8)\n##\n(\"relationship\"<|>VITAMINA A<|>FIBROSIS QUÍSTICA<|>Vitamin A may be supplemented in patients with Fibrosis Quística to support health and prevent deficiencies<|>6)\n<|COMPLETE|>"}]}